# Eloralintide phase 1: single doses and weight at 4 weeks

Source: https://pepvault.app/research/eloralintide-briere-2025

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Eloralintide](https://pepvault.app/research#eloralintide)

Randomized trial · people

# Eloralintide: -4.4% body weight at week 4 in a single-dose trial

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In healthy people, one dose of eloralintide was mostly well tolerated and lowered weight over 4 weeks, but this single-dose trial does not show what repeated dosing does in people with obesity.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 48
- **Published:** 2025
- **Journal:** Mol Metab

## What they tested

The team tested how eloralintide acts on amylin-related receptors in cells, what it does to eating and weight in rats, and whether single doses are safe and tolerated in healthy people.

## How the study was done

Lab tests in cell lines carrying rat or human amylin or calcitonin receptors, studies in rats and monkeys, and a phase 1 randomized, placebo-controlled, blinded trial of single rising doses (0.04-12 mg) in 48 healthy participants. In the trial, neither participants nor investigators knew who got the drug or placebo (a dummy treatment).

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking eloralintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

In cell lines, eloralintide favored the human AMY1R receptor, activating it 12-fold more than CTR and 11-fold more than AMY3R. In rats, it caused less conditioned taste avoidance (a learned dislike of a taste) than cagrilintide (p < 0.05), and in diet-induced obese rats it lowered food intake and body weight in a dose-dependent way, mostly through fat loss. In the human trial, participants on eloralintide reported 16 adverse events, and 15 of the 16 were mild; there were 4 gastrointestinal events, including one moderate vomiting event. At week 4, body weight changed by -2.5% in the 4 mg arm (p < 0.01) and -4.4% in the 12 mg arm (p < 0.001), vs +0.6% on placebo.

## What it doesn’t show

The human part was a small phase 1 safety trial of single doses in healthy people, with weight checked at week 4, so it does not show long-term weight loss or safety in people with obesity. The receptor, taste avoidance and fat loss results come from cells and rats, not people.

## The paper

Briere et al. Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept. Mol Metab. 2025.

- [PubMed (PMID 41109426)](https://pubmed.ncbi.nlm.nih.gov/41109426/)
- [The paper (DOI 10.1016/j.molmet.2025.102271)](https://doi.org/10.1016/j.molmet.2025.102271)
- [ClinicalTrials.gov (NCT05295940)](https://clinicaltrials.gov/study/NCT05295940)

## The compound

- [Eloralintide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/eloralintide)
- [Eloralintide dose guide](https://pepvault.app/lab/dosage/eloralintide)

## With this study

### Eloralintide

- [Eloralintide: the full reference](https://pepvault.app/peptides/eloralintide)
- [Eloralintide dose guide](https://pepvault.app/lab/dosage/eloralintide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/eloralintide-10mg)

### Studies

- [Eloralintide: 2.6% to 11.3% weight loss at 12 weeks in phase 1](https://pepvault.app/research/eloralintide-bhattachar-2026)
- [All 2 studies](https://pepvault.app/research#eloralintide)

### Compared with

- [Cagrilintide vs Eloralintide](https://pepvault.app/peptides/compare/cagrilintide-vs-eloralintide)
- [Eloralintide vs Petrelintide](https://pepvault.app/peptides/compare/eloralintide-vs-petrelintide)
- [Tirzepatide vs Eloralintide](https://pepvault.app/peptides/compare/tirzepatide-vs-eloralintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on Eloralintide

- [Eloralintide: 2.6% to 11.3% weight loss at 12 weeks in phase 1](https://pepvault.app/research/eloralintide-bhattachar-2026) Randomized trial · people · 2026
- [Every study on Eloralintide](https://pepvault.app/research#eloralintide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking eloralintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking eloralintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Eloralintide

- [Eloralintide: the full reference](https://pepvault.app/peptides/eloralintide)
- [Eloralintide dose guide](https://pepvault.app/lab/dosage/eloralintide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/eloralintide-10mg)

### Studies

- [Eloralintide: 2.6% to 11.3% weight loss at 12 weeks in phase 1](https://pepvault.app/research/eloralintide-bhattachar-2026)
- [All 2 studies](https://pepvault.app/research#eloralintide)

### Compared with

- [Cagrilintide vs Eloralintide](https://pepvault.app/peptides/compare/cagrilintide-vs-eloralintide)
- [Eloralintide vs Petrelintide](https://pepvault.app/peptides/compare/eloralintide-vs-petrelintide)
- [Tirzepatide vs Eloralintide](https://pepvault.app/peptides/compare/tirzepatide-vs-eloralintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking eloralintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Eloralintide](https://pepvault.app/research#eloralintide)

## The library

- [Eloralintide](https://pepvault.app/peptides/eloralintide)
- [Eloralintide dose guide](https://pepvault.app/lab/dosage/eloralintide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
